Oxford Biotrans
Oxford
About Oxford Biotrans
Oxford Biotrans Ltd is committed to commercialising new enzymatic routes to high value speciality chemicals based on its patented cytochrome P450 enzyme technology. The company is supported by over 15 years of research by Dr Luet Lok Wong from the Department of Chemistry at the University of Oxford. The first products to market will be flavours and fragrances. The technology also has applications in the production of pheromones, pharmaceuticals and other speciality chemicals.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2017)
- Website: oxfordbiotrans.com
- Phone: 44 7852 926 464
Industries & Categories
Biotechnology, Commercial, Universities
Social Profiles
Canonical: https://fsome.com/organization/oxford-biotrans-90332 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.